Ensuring GLP-1s are covered by Medicaid in all states would save lives—and not be as costly as some people fear.

Consumers have one major defense against rising costs, shrinking provider networks and disappearing benefits: Medicare’s fall ...

Some might also consider switching to Medicare Advantage plans with prescription coverage. But those plans can have more ...

Pharmaceutical giant AstraZeneca will offer U.S. patients discounted prices for some drugs, President Trump announced Friday, ...

Trump is set to announce a deal with AstraZeneca to cut U.S. drug prices using a “most-favored-nation” pricing model.

Justine Mallatt ([email protected]), Bureau of Economic Analysis, Washington, D.C. Abe Dunn, Bureau of Economic Analysis. Lasanthi Fernando, Bureau of Economic Analysis. A 2023 KFF survey reported ...

Health plans develop formularies to provide enrollees access to treatments for a full range of conditions that will improve health outcomes. But when selecting these medications, insurance companies ...

ROCHESTER, N.Y. (WROC) — Excellus BlueCross BlueShield is pushing back against reports that it will no longer cover GLP-1 medications, saying drugs used to treat certain medical conditions remain ...

The ease of acquiring prior authorizations for a new formulary drug plays a part in evaluating oncology drugs that are new to the market. Iannucci: We have a pretty robust formulary review process for ...

DHA's decision to end the coverage violates DOD's own regulations regarding Tricare for Life beneficiaries, the author of this op-ed argues. (Sebastien Bozon/AFP via Getty Images) At 69 years old, ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.